# Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination

> **NCT05313048** · — · COMPLETED · sponsor: **Cardioangiologisches Centrum Bethanien** · enrollment: 82 (actual)

## Conditions studied

- Antiphospholipid Syndrome
- COVID-19 Infection
- COVID-19 Vaccination

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05313048
- **Lead sponsor:** Cardioangiologisches Centrum Bethanien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2022-10-24
- **Final completion:** 2022-10-24
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2022-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05313048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05313048, "Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05313048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*